The subset of CD8+CD38hiHLA-DR+ T cells was considered overactivated with diminished effector function, prone to apoptosis, related to immune dysregulation, systemic inflammation and tissue injury in severe COVID-19 patients (48). This evidence concerns the gene CD8A and COVID-19.